Kag: there is a big difference between Abbott notifying BOCX that RECAF can be integrated on ARCHITECT and Abbott actually providing some clinical data. The latter might not come for another year or more, and that is the important thing
RECAF is a Mab based serum test like many of the other tests on the ARCHITECT test menu so I've been assuming that this step wouldn't be a problem. If it were some DNA based test or something, that would be a concern, but this is a standard monoclonal antibody serum test so integration onto ARCHITECT is really a non-issue.
The big issue here is data people. When will we get some frigging data, whether from Abbott or a third party reference lab like CRL or Quest.
Kag, a question. Are you not frustrated and confused that every single piece of clinical data on RECAF has come out of the company itself or some unknown foreign scientist out on his own???!?!? This is perhaps the easiest problem to solve and Moro has done nothing on this front for years and years.
DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.
